Onbehandelde patiënten
WAVELINE-011 (MK-2140-011)
A Randomized, Open-label, Multicenter, Phase 2 Study Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vdotin Plus R-CHP) in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL)
- Principal investigator: Prof. Dr. Vibeke Vergote
- More information: NCT06890884
- Internal reference number: S70142
Behandelde patiënten
MALT1 (M23-324)
A First-in-Human Study of ABBV-525 (MALT1 Inhibitor) in B-Cell Malignancies
- Principal investigator: Prof. Dr. Ann Janssens
- More information: NCT05618028
- Internal reference number: S67551
Atalanta-1 (CP0201-NHL)
A phase I/II, multicenter study evaluating the feasibility, safety, and efficacy of point-of-care manufactured GLPG5101 (19CP02) in subjects with relapsed/refractory B-cell non-Hodgkin lymphoma
- Principal investigator: Prof. Dr. Peter Vandenberghe
- More information: NCT06561425
- Internal reference number: S61842
Vragen en contact
-
Via deze weg kunt u geen afspraak maken.